MENU
+Compare
INIS
Stock ticker: OTC
AS OF
Sep 4 closing price
Price
$0.07
Change
-$0.01 (-12.50%)
Capitalization
37.02M

INIS International Isotopes, Inc. Forecast, Technical & Fundamental Analysis

International Isotopes Inc manufactures a full range of nuclear medicine calibration and reference standards, cobalt teletherapy sources, and other sealed sources... Show more

INIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for INIS with price predictions
Sep 05, 2025

INIS in downward trend: price dove below 50-day moving average on August 26, 2025

INIS moved below its 50-day moving average on August 26, 2025 date and that indicates a change from an upward trend to a downward trend. In of 90 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 13, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on INIS as a result. In of 161 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for INIS crossed bearishly below the 50-day moving average on August 27, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 24 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INIS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

INIS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 103 cases where INIS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INIS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.681) is normal, around the industry mean (16.681). P/E Ratio (0.000) is within average values for comparable stocks, (74.219). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.902). INIS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (2.498) is also within normal values, averaging (42.934).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INIS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
INIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
4137 Commerce Circle
Phone
+1 208 524-5300
Employees
40
Web
https://www.intisoid.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AITVF0.03N/A
N/A
Asian Television Network International, Ltd.
ANGGF0.28N/A
N/A
Angang Steel Company Limited
FLRAF1.57N/A
N/A
Essentra PLC
NDEKF22.77N/A
N/A
Nitto Denko Corp.
LCGMF0.09N/A
-0.49%
LION COPPER & GOLD CORP.

INIS and Stocks

Correlation & Price change

A.I.dvisor tells us that INIS and HLTRF have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INIS and HLTRF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INIS
1D Price
Change %
INIS100%
N/A
HLTRF - INIS
17%
Poorly correlated
N/A
GRUSF - INIS
10%
Poorly correlated
-0.25%
HSTI - INIS
9%
Poorly correlated
N/A
HYPMY - INIS
3%
Poorly correlated
+1.57%
IPSEF - INIS
2%
Poorly correlated
N/A
More

Groups containing INIS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INIS
1D Price
Change %
INIS100%
N/A
Pharmaceuticals: Generic
industry (222 stocks)
16%
Poorly correlated
+2.50%